PT3413897T - Métodos de tratamento e profilaxia do vih e sida - Google Patents

Métodos de tratamento e profilaxia do vih e sida

Info

Publication number
PT3413897T
PT3413897T PT177061025T PT17706102T PT3413897T PT 3413897 T PT3413897 T PT 3413897T PT 177061025 T PT177061025 T PT 177061025T PT 17706102 T PT17706102 T PT 17706102T PT 3413897 T PT3413897 T PT 3413897T
Authority
PT
Portugal
Prior art keywords
hiv
aids
treatment
prophylaxis methods
prophylaxis
Prior art date
Application number
PT177061025T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of PT3413897T publication Critical patent/PT3413897T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
PT177061025T 2016-02-12 2017-02-10 Métodos de tratamento e profilaxia do vih e sida PT3413897T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662294576P 2016-02-12 2016-02-12
US201662297657P 2016-02-19 2016-02-19

Publications (1)

Publication Number Publication Date
PT3413897T true PT3413897T (pt) 2023-08-28

Family

ID=58057333

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177061025T PT3413897T (pt) 2016-02-12 2017-02-10 Métodos de tratamento e profilaxia do vih e sida

Country Status (37)

Country Link
US (4) US10537589B2 (cg-RX-API-DMAC7.html)
EP (1) EP3413897B1 (cg-RX-API-DMAC7.html)
JP (4) JP6810972B2 (cg-RX-API-DMAC7.html)
KR (4) KR20220126787A (cg-RX-API-DMAC7.html)
CN (2) CN108697727A (cg-RX-API-DMAC7.html)
AU (3) AU2017217656B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018016349A2 (cg-RX-API-DMAC7.html)
CA (1) CA3013473C (cg-RX-API-DMAC7.html)
CL (1) CL2018002150A1 (cg-RX-API-DMAC7.html)
DK (1) DK3413897T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2018000183A (cg-RX-API-DMAC7.html)
EA (1) EA201891814A1 (cg-RX-API-DMAC7.html)
ES (1) ES2953535T3 (cg-RX-API-DMAC7.html)
FI (1) FI3413897T3 (cg-RX-API-DMAC7.html)
GE (2) GEP20217231B (cg-RX-API-DMAC7.html)
HR (1) HRP20230935T1 (cg-RX-API-DMAC7.html)
HU (1) HUE063532T2 (cg-RX-API-DMAC7.html)
IL (1) IL260874B2 (cg-RX-API-DMAC7.html)
JO (1) JOP20170038B1 (cg-RX-API-DMAC7.html)
LT (1) LT3413897T (cg-RX-API-DMAC7.html)
MD (1) MD3413897T2 (cg-RX-API-DMAC7.html)
MX (3) MX390604B (cg-RX-API-DMAC7.html)
MY (1) MY197090A (cg-RX-API-DMAC7.html)
NI (1) NI201800083A (cg-RX-API-DMAC7.html)
NZ (1) NZ745065A (cg-RX-API-DMAC7.html)
PH (1) PH12018501712A1 (cg-RX-API-DMAC7.html)
PL (1) PL3413897T3 (cg-RX-API-DMAC7.html)
PT (1) PT3413897T (cg-RX-API-DMAC7.html)
RS (1) RS64448B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201806783WA (cg-RX-API-DMAC7.html)
SI (1) SI3413897T1 (cg-RX-API-DMAC7.html)
SV (1) SV2018005733A (cg-RX-API-DMAC7.html)
TN (1) TN2018000267A1 (cg-RX-API-DMAC7.html)
TW (3) TWI822652B (cg-RX-API-DMAC7.html)
UA (1) UA126375C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017139519A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201805073B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20170038B1 (ar) * 2016-02-12 2021-08-17 Merck Sharp & Dohme مركبات للاستخدام لعلاج عدوى بفيروس hiv والوقاية منه
US20200138845A1 (en) * 2017-07-18 2020-05-07 Viiv Healthcare Company Combination Drug Therapy
CN109893536B (zh) * 2018-07-02 2021-04-27 河南真实生物科技有限公司 4’-取代核苷的晶型、制备和应用
WO2020018352A1 (en) 2018-07-17 2020-01-23 Merck Sharp & Dohme Corp. Hiv drug combination for increasing barrier against resistance
EP3897660A4 (en) * 2018-12-20 2022-09-07 Merck Sharp & Dohme Corp. NEW CRYSTALLINE FORMS OF AN NRTTI COMPOUND
MX2021008751A (es) 2019-01-25 2021-11-12 Univ Brown Composiciones y metodos para tratar, prevenir o revertir la inflamacion y los trastornos asociados a la edad.
PH12021500034A1 (en) 2019-03-06 2022-06-06 Glaxosmithkline Ip No 2 Ltd Compounds useful in hiv therapy
IL289925B2 (en) 2019-07-27 2026-03-01 Brii Biosciences Inc A derivative of adenosine and a pharmaceutical preparation containing it
EP4358968A4 (en) * 2021-06-22 2025-05-07 Rome Therapeutics, Inc. 4-ETHINYL-3-HYDROXY-TETRAHYDROFURANYL ADENINE PHOSPHORAMIDATE AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISEASES
WO2023196832A2 (en) * 2022-04-06 2023-10-12 Brii Biosciences, Inc. Pharmaceutical composition and method for treatment of human immunodeficiency virus infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2276404T3 (es) * 1995-06-07 2007-06-16 Emory University Nucleosidos con actividad antivirus de la hepatitis-b.
KR20110079783A (ko) 2003-02-19 2011-07-07 예일 유니버시티 항-바이러스 뉴클레오시드 유사체 및 바이러스 감염, 특히 에이치아이브이 감염의 치료방법
CA2502109C (en) * 2004-03-24 2010-02-23 Yamasa Corporation 4'-c-substituted-2-haloadenosine derivative
US8513205B2 (en) * 2008-04-11 2013-08-20 Yale University Potent chimeric NRTI-NNRTI bifunctional inhibitors of HIV-1 reverse transcriptase
WO2012099630A1 (en) * 2011-01-20 2012-07-26 University Of Rochester Compositions and methods for treating or preventing a retrovirus infection
WO2015143712A1 (en) * 2014-03-28 2015-10-01 Merck Sharp & Dohme Corp. 4'-substituted nucleoside reverse transcriptase inhibitors
JP6768796B2 (ja) 2015-09-23 2020-10-14 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 4’−置換ヌクレオシド逆転写酵素阻害剤及びその調製
JOP20170038B1 (ar) * 2016-02-12 2021-08-17 Merck Sharp & Dohme مركبات للاستخدام لعلاج عدوى بفيروس hiv والوقاية منه
JP6934019B2 (ja) * 2016-05-12 2021-09-08 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 抗ウイルス薬を送達するための薬物送達システム
EP3471829A4 (en) * 2016-06-20 2020-01-15 Merck Sharp & Dohme Corp. ACTIVE SUBSTANCE RELEASE SYSTEM FOR RELEASING VIRUZIDS
US20200138845A1 (en) * 2017-07-18 2020-05-07 Viiv Healthcare Company Combination Drug Therapy
CN114206336A (zh) * 2019-08-13 2022-03-18 默沙东公司 用于递送抗病毒剂的药物递送系统
US20230149296A1 (en) * 2020-05-05 2023-05-18 Merck Sharp & Dohme Llc Drug delivery system for the delivery of antiviral agents and contraceptives
US20230310309A1 (en) * 2020-08-25 2023-10-05 Merck Sharp & Dohme Llc Injectable depot compositions for the delivery of antiviral agents

Also Published As

Publication number Publication date
US20250073254A1 (en) 2025-03-06
JP7559175B2 (ja) 2024-10-01
TWI822652B (zh) 2023-11-21
FI3413897T3 (fi) 2023-08-25
RS64448B1 (sr) 2023-09-29
CA3013473A1 (en) 2017-08-17
GEP20207190B (en) 2020-12-10
AU2017217656B2 (en) 2020-01-30
NI201800083A (es) 2018-10-05
JP7021314B2 (ja) 2022-02-16
MY197090A (en) 2023-05-24
JP6810972B2 (ja) 2021-01-13
MX2022002924A (es) 2022-12-15
KR20210049201A (ko) 2021-05-04
TW201731514A (zh) 2017-09-16
KR20220126787A (ko) 2022-09-16
JP2021001189A (ja) 2021-01-07
GEP20217231B (en) 2021-03-25
WO2017139519A1 (en) 2017-08-17
KR20180108815A (ko) 2018-10-04
JP2022062170A (ja) 2022-04-19
AU2022201686A1 (en) 2022-03-31
TW202417010A (zh) 2024-05-01
TWI911551B (zh) 2026-01-11
DK3413897T3 (da) 2023-09-18
LT3413897T (lt) 2023-08-25
US20220331350A1 (en) 2022-10-20
US20200101098A1 (en) 2020-04-02
JP7559175B6 (ja) 2024-10-22
CA3013473C (en) 2021-10-26
EP3413897B1 (en) 2023-06-14
EA201891814A1 (ru) 2019-01-31
JP2019504857A (ja) 2019-02-21
IL260874B2 (en) 2023-10-01
US20180055867A1 (en) 2018-03-01
MX390604B (es) 2025-03-20
AU2017217656A1 (en) 2018-08-23
AU2020202866A1 (en) 2020-05-21
IL260874A (cg-RX-API-DMAC7.html) 2018-09-20
MD3413897T2 (ro) 2023-11-30
HRP20230935T1 (hr) 2023-11-24
UA126375C2 (uk) 2022-09-28
CN108697727A (zh) 2018-10-23
ES2953535T3 (es) 2023-11-14
MX2022002925A (es) 2023-02-10
US10537589B2 (en) 2020-01-21
CL2018002150A1 (es) 2018-12-14
HUE063532T2 (hu) 2024-01-28
AU2020202866B2 (en) 2022-04-07
KR20250136420A (ko) 2025-09-16
SV2018005733A (es) 2018-12-14
TW202610660A (zh) 2026-03-16
NZ784982A (en) 2025-03-28
TN2018000267A1 (en) 2020-01-16
US11337991B2 (en) 2022-05-24
DOP2018000183A (es) 2018-12-31
GEAP202014873A (en) 2020-07-27
EP3413897A1 (en) 2018-12-19
BR112018016349A2 (pt) 2018-12-26
CN113509480A (zh) 2021-10-19
PL3413897T3 (pl) 2023-10-02
SI3413897T1 (sl) 2023-11-30
US12171776B2 (en) 2024-12-24
SG11201806783WA (en) 2018-09-27
MX2018009763A (es) 2018-11-29
ZA201805073B (en) 2019-05-29
PH12018501712A1 (en) 2019-05-15
HK1257347A1 (en) 2019-10-18
JP2024001206A (ja) 2024-01-09
KR102317570B1 (ko) 2021-10-25
NZ745065A (en) 2023-11-24
IL260874B1 (en) 2023-06-01
AU2022201686B2 (en) 2024-08-08
JOP20170038B1 (ar) 2021-08-17

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
IL269371A (en) Treatment methods
AU2017217656B2 (en) Methods for treatment and prophylaxis of HIV and aids
HRP20190352T1 (hr) Novi 6-kondenzirani heteroarildihidropirimidini za liječenje i profilaksu infekcije virusom hepatitisa b
EP3581321A4 (en) LASER TREATMENT DEVICE AND METHOD
EP3565371A4 (en) SESSION PROCESSING METHOD AND DEVICE
SI3785717T1 (sl) Postopki za zdravljenje okužb s Coronaviridae
EP3960735C0 (en) QUINAZOLINE DERIVATIVES USED TO TREAT HIV
IL273932A (en) Methods of treatment and prevention of viral infection
HRP20181130T1 (hr) Postupci za liječenje infekcija virusom filoviridae
HUE052104T2 (hu) Eszközök és eljárások HBV kezelésére
EP3160475C0 (en) NUCLEOSIDES AND SUBSTITUTED NUCLEOTIDES FOR TREATING INFECTIONS DUE TO FILOVIRIDAE
EP3519833A4 (en) PROCEDURE FOR PROGNOSIS AND TREATMENT
SG11201609652RA (en) Treatment of polybacterials infections
SG11201808246SA (en) Methods for treating and preventing c. difficile infection
EP3915472C0 (en) DEVICE FOR TREATING VAGINAL ATROPHY
PL3493812T3 (pl) Połączenia imetelstatu i wenetoklaksu do leczenia ostrej białaczki szpikowej
PT3265087T (pt) Método de tratamento com tradipitant
BR112018000204A2 (pt) métodos de tratamento de colite
EP3657744A4 (en) Message processing
IL271987A (en) Regimens for the treatment of HIV infections and AIDS
EP3431517A4 (en) Copolymer and surface treatment
ES2893126T8 (es) Métodos de tratamiento de afecciones oculares
EP3522865A4 (en) METHOD AND COMPOSITIONS FOR TREATING STRIAE DISTENSAE
DK3302478T3 (da) Pac-1 kombinations behandling